WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

EVIDENCE-BASED NUTRITION PATTERNS AND LIFESTYLE COUNSELLING IN TYPE 2 DIABETES CARE: BRIDGING GAPS WITH PERSONALIZED, DIGITAL, AND LMIC-TAILORED INNOVATIONS – A SYSTEMATIC REVIEW

Pillarikuppam Pavani, Anusha Konamsetti, G. Bhavya, D. Thilak, Niraj Kumar,

Dr. D. Ravi Kiran*

Abstract

Type 2 diabetes (T2D) affects over 500 million people globally, with India facing 11-15% prevalence amid rapid urbanization and lifestyle shifts. while RCTs endorse low-glycemic index with Mediterranean low-carbohydrate and plant-based diets for HbA1c reductions of 0.5-1.2%, weight loss, and cardiovascular benefits. persistent gaps include poor long-term adherence (>40% dropout), unaffordable Low- and Middle-Income Countries adaptations (e.g., olive oil, nuts), and limited personalization for genetic/ethnic factors like key proteincoding gene located on chromosome 10q25.2–q25.3 variants. This PROSPERO-registered systematic review synthesizes 2023-2026 RCTs, network meta-analyses and cohorts (n>50 trials) from PubMed, Embase, Cochrane, and grey literature up to January 2026, evaluating glycaemic control, adherence, costeffectiveness, and quality of life via GRADE-rated metaanalyses; LGI-Mediterranean hybrids excelled in Low- and Middle-Income Countries with digital interventions (apps, wearables) enhancing adherence by 25-35% through real-time feedback. We propose hybrid AI-driven models for Indian contexts—culturally adapted low-glycaemic index. plates featuring millets and lentils, pharmacogenomics-integrated mobile apps, and rural tele-counselling—leveraging predictive analytics for relapse prevention and pharmacoeconomic gains Incremental Cost-Effectiveness Ratio less than $500 per Quality-Adjusted Life Year), thereby bridging evidence-to-practice gaps with scalable, equity-focused innovations to mitigate Type 2 diabetes epidemic.

Keywords: Network meta-analyses (NMAs), Type 2 diabetes (T2D) ,low-glycemic index (LGI).


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More